<?xml version="1.0" encoding="UTF-8"?>
<xml>
 <records>
  <record>
   <ref-type name="Journal Article">17</ref-type>
   <contributors>
    <authors>
     <author>Yunusbayev, B.</author>
     <author>Ryakhovsky, S.</author>
     <author>Altinbaev, R.</author>
     <author>Kislova, A.</author>
     <author>Danilko, K.V.</author>
     <author>Kraeva, L.</author>
     <author>Yunusbaeva, M.</author>
    </authors>
   </contributors>
   <titles>
    <title>Psoriasis risk allele function in activated Th1/17 cells with “memory” to antigen exposure</title>
   </titles>
   <keywords>
    <keyword>Scopus</keyword>
    <keyword>Web of Science</keyword>
    <keyword>Белый список</keyword>
   </keywords>
   <dates>
    <year>2026</year>
    <pub-dates>
     <date>2026-06-06</date>
    </pub-dates>
   </dates>
   <doi>10.1371/journal.pone.0344675</doi>
   <journal>PLOS ONE</journal>
   <abstract>Most causal variants for complex diseases are expected to affect gene regulation in&#13;
a cell- and context-specific manner. Hence, identification of such dynamically functioning variants requires functional readouts in disease-relevant tissues and context.&#13;
In this study, we prioritized causal variants for psoriasis by adding functional annotations from disease-relevant cells. We demonstrate that disease-relevant immune&#13;
cells, unlike most other tissues, possess functional annotations that match candidate&#13;
causal SNPs. Specifically, we identified an eQTL, rs4672505, that reduces B3GNT2&#13;
gene expression only in Th1/Th17 cells with a memory phenotype, i.e., antigenexperienced T helper cells. This eQTL, a likely causal variant, also matched an&#13;
enhancer chromatin mark exclusive to memory T helper cells and absent in other&#13;
tissues. A disease-risk allele A at the eQTL correlates with reduced expression of the&#13;
B3GNT2 glycosyltransferase. B3GNT2 deficiency in murine models reduces the glycosylation of the CD28 co-receptor involved in the CD28/B7 co-stimulation pathway&#13;
and results in increased T cell activation upon antigen stimulation. We hypothesize&#13;
that the risk allele A in patients increases the activation of memory Th1/Th17 cells&#13;
upon re-exposure to antigens, which constitutes “signal 1”. Increased reactivity to&#13;
antigens depends on “signal 2” via CD28/B7 co-stimulation from antigen-presenting&#13;
cells that need to encounter microbial products. Hence, this genetic risk mechanism&#13;
lies at the nexus of the response to specific antigens and microbial exposure, for&#13;
instance, infection or vaccination, both of which are known to exacerbate psoriasis.</abstract>
   <urls>
    <web-urls>
     <url>https://repo.bashgmu.ru/publication/5486</url>
    </web-urls>
    <pdf-urls>
     <url>https://repo.bashgmu.ru/files/5680</url>
    </pdf-urls>
   </urls>
  </record>
 </records>
</xml>
